These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 29204700)

  • 1. The Immunoscore system predicts prognosis after liver metastasectomy in colorectal cancer liver metastases.
    Wang Y; Lin HC; Huang MY; Shao Q; Wang ZQ; Wang FH; Yuan YF; Li BK; Wang DS; Ding PR; Chen G; Wu XJ; Lu ZH; Li LR; Pan ZZ; Sun P; Yan SM; Wan DS; Xu RH; Li YH
    Cancer Immunol Immunother; 2018 Mar; 67(3):435-444. PubMed ID: 29204700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathological growth patterns correlate with the immunoscore in colorectal cancer liver metastasis patients after hepatectomy.
    Liang JY; Xi SY; Shao Q; Yuan YF; Li BK; Zheng Y; Wang DS; Wu XJ; Ding PR; Chen G; Li LR; Wang FH; Wang ZQ; Pan ZZ; Xu RH; Li YH
    Cancer Immunol Immunother; 2020 Dec; 69(12):2623-2634. PubMed ID: 32601799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on Survival.
    Mlecnik B; Van den Eynde M; Bindea G; Church SE; Vasaturo A; Fredriksen T; Lafontaine L; Haicheur N; Marliot F; Debetancourt D; Pairet G; Jouret-Mourin A; Gigot JF; Hubert C; Danse E; Dragean C; Carrasco J; Humblet Y; Valge-Archer V; Berger A; Pagès F; Machiels JP; Galon J
    J Natl Cancer Inst; 2018 Jan; 110(1):. PubMed ID: 28922789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic assessment of resected colorectal liver metastases integrating pathological features, RAS mutation and Immunoscore.
    Baldin P; Van den Eynde M; Mlecnik B; Bindea G; Beniuga G; Carrasco J; Haicheur N; Marliot F; Lafontaine L; Fredriksen T; Lanthier N; Hubert C; Navez B; Huyghe N; Pagès F; Jouret-Mourin A; Galon J; Komuta M
    J Pathol Clin Res; 2021 Jan; 7(1):27-41. PubMed ID: 32902189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory T cell infiltration predicts outcome following resection of colorectal cancer liver metastases.
    Katz SC; Bamboat ZM; Maker AV; Shia J; Pillarisetty VG; Yopp AC; Hedvat CV; Gonen M; Jarnagin WR; Fong Y; D'Angelica MI; DeMatteo RP
    Ann Surg Oncol; 2013 Mar; 20(3):946-55. PubMed ID: 23010736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of clinical risk score for colorectal liver metastases resected in a contemporary multicenter cohort.
    Beamish P; Lemke M; Li J; Dixon E; Abraham MT; Hernandez-Alejandro R; Bennett S; Martel G; Karanicolas PJ;
    HPB (Oxford); 2017 Aug; 19(8):675-681. PubMed ID: 28495435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer.
    Mlecnik B; Bifulco C; Bindea G; Marliot F; Lugli A; Lee JJ; Zlobec I; Rau TT; Berger MD; Nagtegaal ID; Vink-Börger E; Hartmann A; Geppert C; Kolwelter J; Merkel S; Grützmann R; Van den Eynde M; Jouret-Mourin A; Kartheuser A; Léonard D; Remue C; Wang JY; Bavi P; Roehrl MHA; Ohashi PS; Nguyen LT; Han S; MacGregor HL; Hafezi-Bakhtiari S; Wouters BG; Masucci GV; Andersson EK; Zavadova E; Vocka M; Spacek J; Petruzelka L; Konopasek B; Dundr P; Skalova H; Nemejcova K; Botti G; Tatangelo F; Delrio P; Ciliberto G; Maio M; Laghi L; Grizzi F; Fredriksen T; Buttard B; Lafontaine L; Bruni D; Lanzi A; El Sissy C; Haicheur N; Kirilovsky A; Berger A; Lagorce C; Paustian C; Ballesteros-Merino C; Dijkstra J; van de Water C; van Lent-van Vliet S; Knijn N; Muşină AM; Scripcariu DV; Popivanova B; Xu M; Fujita T; Hazama S; Suzuki N; Nagano H; Okuno K; Torigoe T; Sato N; Furuhata T; Takemasa I; Itoh K; Patel PS; Vora HH; Shah B; Patel JB; Rajvik KN; Pandya SJ; Shukla SN; Wang Y; Zhang G; Kawakami Y; Marincola FM; Ascierto PA; Fox BA; Pagès F; Galon J
    J Clin Oncol; 2020 Nov; 38(31):3638-3651. PubMed ID: 32897827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histological tumor response to neoadjuvant chemotherapy correlates to Immunoscore in colorectal cancer liver metastases patients.
    Zhang C; Wang X; Han J; Zhang R; Chen Z; Li Y; Ma X; Zhang G; Fan J; Chen J
    J Surg Oncol; 2021 Dec; 124(8):1431-1441. PubMed ID: 34406653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Efficient Prognostic Immune Scoring System For Colorectal Cancer Patients With Peritoneal Metastasis.
    Zhao Y; Chen C; Xu X; Ge X; Ding K; Zheng S; Wang J; Sun L
    Oncoimmunology; 2021 Mar; 10(1):1901464. PubMed ID: 33796414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC.
    Gabrielson A; Wu Y; Wang H; Jiang J; Kallakury B; Gatalica Z; Reddy S; Kleiner D; Fishbein T; Johnson L; Island E; Satoskar R; Banovac F; Jha R; Kachhela J; Feng P; Zhang T; Tesfaye A; Prins P; Loffredo C; Marshall J; Weiner L; Atkins M; He AR
    Cancer Immunol Res; 2016 May; 4(5):419-30. PubMed ID: 26968206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoscore encompassing CD3+ and CD8+ T cell densities in distant metastasis is a robust prognostic marker for advanced colorectal cancer.
    Kwak Y; Koh J; Kim DW; Kang SB; Kim WH; Lee HS
    Oncotarget; 2016 Dec; 7(49):81778-81790. PubMed ID: 27835889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inclusion of BLIMP-1
    Ward-Hartstonge KA; McCall JL; McCulloch TR; Kamps AK; Girardin A; Cretney E; Munro FM; Kemp RA
    Cancer Immunol Immunother; 2017 Apr; 66(4):515-522. PubMed ID: 28116480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma.
    Chen QF; Li W; Wu PH; Shen LJ; Huang ZL
    World J Gastroenterol; 2019 Sep; 25(35):5266-5282. PubMed ID: 31558872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficient circulating immunoscore predicts prognosis of patients with advanced gastrointestinal cancer.
    Zhao Y; Tang Y; Qin H; Feng K; Hu C
    World J Surg Oncol; 2022 Jul; 20(1):233. PubMed ID: 35820903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic response to preoperative chemotherapy predicts prognosis for patients undergoing surgical resection of colorectal cancer metastatic to the liver.
    Lau LF; Williams DS; Lee ST; Scott AM; Christophi C; Muralidharan V
    Ann Surg Oncol; 2014 Jul; 21(7):2420-8. PubMed ID: 24595797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of tumour size ratio on liver recurrence-free survival of patients undergoing hepatic resection for colorectal liver metastases.
    Zhai Y; Bai W; Zhou J; Dong Q; Zhang J
    BMC Cancer; 2022 Jan; 22(1):103. PubMed ID: 35078439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization and density of tertiary lymphoid structures associate with molecular subtype and clinical outcome in colorectal cancer liver metastases.
    Zhang C; Wang XY; Zuo JL; Wang XF; Feng XW; Zhang B; Li YT; Yi CH; Zhang P; Ma XC; Chen ZM; Ma Y; Han JH; Tao BR; Zhang R; Wang TQ; Tong L; Gu W; Wang SY; Zheng XF; Yuan WK; Kan ZJ; Fan J; Hu XY; Li J; Zhang C; Chen JH
    J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36759015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
    Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
    [No Abstract]   [Full Text] [Related]  

  • 19. Improving the clinical risk score: an analysis of molecular biomarkers in the era of modern chemotherapy for resectable hepatic colorectal cancer metastases.
    Maithel SK; Gönen M; Ito H; Dematteo RP; Allen PJ; Fong Y; Blumgart LH; Jarnagin WR; D'Angelica MI
    Surgery; 2012 Feb; 151(2):162-70. PubMed ID: 21982065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating PD-L1 is associated with T cell infiltration and predicts prognosis in patients with CRLM following hepatic resection.
    Chen X; Du Z; Huang M; Wang D; Fong WP; Liang J; Fan L; Wang Y; Yang H; Chen Z; Hu M; Xu R; Li Y
    Cancer Immunol Immunother; 2022 Mar; 71(3):661-674. PubMed ID: 34322779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.